 | • レポートコード：QYR2104Z2362 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、線維筋痛症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・線維筋痛症治療の市場動向 ・企業の競争状況、市場シェア ・線維筋痛症治療の種類別市場規模（シンバルタ（デュロキセチン）、サベラ（ミルナシプラン）、リリカ（プレガバリン）、パンクロニウム、その他） ・線維筋痛症治療の用途別市場規模（病院、クリニック、その他） ・線維筋痛症治療の北米市場規模2016-2027（アメリカ、カナダ） ・線維筋痛症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・線維筋痛症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・線維筋痛症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・線維筋痛症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Eli Lilly、Actavis、Merck Sharp and Dohme、Daiichi Sankyo、Innovative Med Concepts、Meda、Meiji Seika、Switch Biotech、Theravance、Zynerba Pharmaceuticals、Tonix Pharmaceuticals Holding Corp. (TNXP)、Daiichi Sankyo、Forest Pharmaceuticals, Inc.、Boehringer Ingelheim GmbH、Pierre Fabre Mdicament） ・結論 |
Market Analysis and Insights: Global Fibromyalgia Therapeutics Market
The global Fibromyalgia Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fibromyalgia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fibromyalgia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fibromyalgia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fibromyalgia Therapeutics market.
Global Fibromyalgia Therapeutics Scope and Market Size
Fibromyalgia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibromyalgia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cymbalta (Duloxetine)
Savella (Milnacipran)
Lyrica (Pregabalin)
Pancuronium
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Eli Lilly
Actavis
Merck Sharp and Dohme
Daiichi Sankyo
Innovative Med Concepts
Meda
Meiji Seika
Switch Biotech
Theravance
Zynerba Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (TNXP)
Daiichi Sankyo
Forest Pharmaceuticals, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibromyalgia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Market by Application
1.3.1 Global Fibromyalgia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fibromyalgia Therapeutics Market Perspective (2016-2027)
2.2 Fibromyalgia Therapeutics Growth Trends by Regions
2.2.1 Fibromyalgia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fibromyalgia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Fibromyalgia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Fibromyalgia Therapeutics Industry Dynamic
2.3.1 Fibromyalgia Therapeutics Market Trends
2.3.2 Fibromyalgia Therapeutics Market Drivers
2.3.3 Fibromyalgia Therapeutics Market Challenges
2.3.4 Fibromyalgia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fibromyalgia Therapeutics Players by Revenue
3.1.1 Global Top Fibromyalgia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Fibromyalgia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Fibromyalgia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fibromyalgia Therapeutics Revenue
3.4 Global Fibromyalgia Therapeutics Market Concentration Ratio
3.4.1 Global Fibromyalgia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Therapeutics Revenue in 2020
3.5 Fibromyalgia Therapeutics Key Players Head office and Area Served
3.6 Key Players Fibromyalgia Therapeutics Product Solution and Service
3.7 Date of Enter into Fibromyalgia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fibromyalgia Therapeutics Breakdown Data by Type
4.1 Global Fibromyalgia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2022-2027)
5 Fibromyalgia Therapeutics Breakdown Data by Application
5.1 Global Fibromyalgia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Fibromyalgia Therapeutics Market Size (2016-2027)
6.2 North America Fibromyalgia Therapeutics Market Size by Type
6.2.1 North America Fibromyalgia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Fibromyalgia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Fibromyalgia Therapeutics Market Size by Type (2016-2027)
6.3 North America Fibromyalgia Therapeutics Market Size by Application
6.3.1 North America Fibromyalgia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Fibromyalgia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Fibromyalgia Therapeutics Market Size by Application (2016-2027)
6.4 North America Fibromyalgia Therapeutics Market Size by Country
6.4.1 North America Fibromyalgia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Fibromyalgia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Fibromyalgia Therapeutics Market Size (2016-2027)
7.2 Europe Fibromyalgia Therapeutics Market Size by Type
7.2.1 Europe Fibromyalgia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Fibromyalgia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Fibromyalgia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Fibromyalgia Therapeutics Market Size by Application
7.3.1 Europe Fibromyalgia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Fibromyalgia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Fibromyalgia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Fibromyalgia Therapeutics Market Size by Country
7.4.1 Europe Fibromyalgia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Fibromyalgia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fibromyalgia Therapeutics Market Size (2016-2027)
9.2 Latin America Fibromyalgia Therapeutics Market Size by Type
9.2.1 Latin America Fibromyalgia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Fibromyalgia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Fibromyalgia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Fibromyalgia Therapeutics Market Size by Application
9.3.1 Latin America Fibromyalgia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Fibromyalgia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Fibromyalgia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Fibromyalgia Therapeutics Market Size by Country
9.4.1 Latin America Fibromyalgia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Fibromyalgia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fibromyalgia Therapeutics Introduction
11.1.4 Pfizer Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Fibromyalgia Therapeutics Introduction
11.2.4 Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Actavis
11.3.1 Actavis Company Details
11.3.2 Actavis Business Overview
11.3.3 Actavis Fibromyalgia Therapeutics Introduction
11.3.4 Actavis Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.3.5 Actavis Recent Development
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Details
11.4.2 Merck Sharp and Dohme Business Overview
11.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Introduction
11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.4.5 Merck Sharp and Dohme Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Details
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction
11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.5.5 Daiichi Sankyo Recent Development
11.6 Innovative Med Concepts
11.6.1 Innovative Med Concepts Company Details
11.6.2 Innovative Med Concepts Business Overview
11.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Introduction
11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.6.5 Innovative Med Concepts Recent Development
11.7 Meda
11.7.1 Meda Company Details
11.7.2 Meda Business Overview
11.7.3 Meda Fibromyalgia Therapeutics Introduction
11.7.4 Meda Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.7.5 Meda Recent Development
11.8 Meiji Seika
11.8.1 Meiji Seika Company Details
11.8.2 Meiji Seika Business Overview
11.8.3 Meiji Seika Fibromyalgia Therapeutics Introduction
11.8.4 Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.8.5 Meiji Seika Recent Development
11.9 Switch Biotech
11.9.1 Switch Biotech Company Details
11.9.2 Switch Biotech Business Overview
11.9.3 Switch Biotech Fibromyalgia Therapeutics Introduction
11.9.4 Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.9.5 Switch Biotech Recent Development
11.10 Theravance
11.10.1 Theravance Company Details
11.10.2 Theravance Business Overview
11.10.3 Theravance Fibromyalgia Therapeutics Introduction
11.10.4 Theravance Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.10.5 Theravance Recent Development
11.11 Zynerba Pharmaceuticals
11.11.1 Zynerba Pharmaceuticals Company Details
11.11.2 Zynerba Pharmaceuticals Business Overview
11.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Introduction
11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.11.5 Zynerba Pharmaceuticals Recent Development
11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Introduction
11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Introduction
11.13.4 Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.13.5 Daiichi Sankyo Recent Development
11.14 Forest Pharmaceuticals, Inc.
11.14.1 Forest Pharmaceuticals, Inc. Company Details
11.14.2 Forest Pharmaceuticals, Inc. Business Overview
11.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Introduction
11.14.4 Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.14.5 Forest Pharmaceuticals, Inc. Recent Development
11.15 Boehringer Ingelheim GmbH
11.15.1 Boehringer Ingelheim GmbH Company Details
11.15.2 Boehringer Ingelheim GmbH Business Overview
11.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Introduction
11.15.4 Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.15.5 Boehringer Ingelheim GmbH Recent Development
11.16 Pierre Fabre Mdicament
11.16.1 Pierre Fabre Mdicament Company Details
11.16.2 Pierre Fabre Mdicament Business Overview
11.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Introduction
11.16.4 Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2016-2021)
11.16.5 Pierre Fabre Mdicament Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Fibromyalgia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cymbalta (Duloxetine)
Table 3. Key Players of Savella (Milnacipran)
Table 4. Key Players of Lyrica (Pregabalin)
Table 5. Key Players of Pancuronium
Table 6. Key Players of Others
Table 7. Global Fibromyalgia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Fibromyalgia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Fibromyalgia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Fibromyalgia Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Fibromyalgia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Fibromyalgia Therapeutics Market Share by Regions (2022-2027)
Table 13. Fibromyalgia Therapeutics Market Trends
Table 14. Fibromyalgia Therapeutics Market Drivers
Table 15. Fibromyalgia Therapeutics Market Challenges
Table 16. Fibromyalgia Therapeutics Market Restraints
Table 17. Global Fibromyalgia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Fibromyalgia Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Therapeutics as of 2020)
Table 20. Ranking of Global Top Fibromyalgia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Fibromyalgia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Fibromyalgia Therapeutics Product Solution and Service
Table 24. Date of Enter into Fibromyalgia Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Fibromyalgia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Fibromyalgia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Fibromyalgia Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Fibromyalgia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Fibromyalgia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Fibromyalgia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Fibromyalgia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Fibromyalgia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Fibromyalgia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Fibromyalgia Therapeutics Product
Table 67. Pfizer Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Pfizer Recent Development
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Fibromyalgia Therapeutics Product
Table 72. Eli Lilly Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly Recent Development
Table 74. Actavis Company Details
Table 75. Actavis Business Overview
Table 76. Actavis Fibromyalgia Therapeutics Product
Table 77. Actavis Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 78. Actavis Recent Development
Table 79. Merck Sharp and Dohme Company Details
Table 80. Merck Sharp and Dohme Business Overview
Table 81. Merck Sharp and Dohme Fibromyalgia Therapeutics Product
Table 82. Merck Sharp and Dohme Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Merck Sharp and Dohme Recent Development
Table 84. Daiichi Sankyo Company Details
Table 85. Daiichi Sankyo Business Overview
Table 86. Daiichi Sankyo Fibromyalgia Therapeutics Product
Table 87. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Daiichi Sankyo Recent Development
Table 89. Innovative Med Concepts Company Details
Table 90. Innovative Med Concepts Business Overview
Table 91. Innovative Med Concepts Fibromyalgia Therapeutics Product
Table 92. Innovative Med Concepts Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Innovative Med Concepts Recent Development
Table 94. Meda Company Details
Table 95. Meda Business Overview
Table 96. Meda Fibromyalgia Therapeutics Product
Table 97. Meda Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Meda Recent Development
Table 99. Meiji Seika Company Details
Table 100. Meiji Seika Business Overview
Table 101. Meiji Seika Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Meiji Seika Recent Development
Table 103. Switch Biotech Company Details
Table 104. Switch Biotech Business Overview
Table 105. Switch Biotech Fibromyalgia Therapeutics Product
Table 106. Switch Biotech Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Switch Biotech Recent Development
Table 108. Theravance Company Details
Table 109. Theravance Business Overview
Table 110. Theravance Fibromyalgia Therapeutics Product
Table 111. Theravance Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Theravance Recent Development
Table 113. Zynerba Pharmaceuticals Company Details
Table 114. Zynerba Pharmaceuticals Business Overview
Table 115. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Product
Table 116. Zynerba Pharmaceuticals Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 117. Zynerba Pharmaceuticals Recent Development
Table 118. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
Table 119. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
Table 120. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Product
Table 121. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
Table 123. Daiichi Sankyo Company Details
Table 124. Daiichi Sankyo Business Overview
Table 125. Daiichi Sankyo Fibromyalgia Therapeutics Product
Table 126. Daiichi Sankyo Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Daiichi Sankyo Recent Development
Table 128. Forest Pharmaceuticals, Inc. Company Details
Table 129. Forest Pharmaceuticals, Inc. Business Overview
Table 130. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Product
Table 131. Forest Pharmaceuticals, Inc. Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 132. Forest Pharmaceuticals, Inc. Recent Development
Table 133. Boehringer Ingelheim GmbH Company Details
Table 134. Boehringer Ingelheim GmbH Business Overview
Table 135. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Product
Table 136. Boehringer Ingelheim GmbH Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 137. Boehringer Ingelheim GmbH Recent Development
Table 138. Pierre Fabre Mdicament Company Details
Table 139. Pierre Fabre Mdicament Business Overview
Table 140. Pierre Fabre Mdicament Fibromyalgia Therapeutics Product
Table 141. Pierre Fabre Mdicament Revenue in Fibromyalgia Therapeutics Business (2016-2021) & (US$ Million)
Table 142. Pierre Fabre Mdicament Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibromyalgia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Cymbalta (Duloxetine) Features
Figure 3. Savella (Milnacipran) Features
Figure 4. Lyrica (Pregabalin) Features
Figure 5. Pancuronium Features
Figure 6. Others Features
Figure 7. Global Fibromyalgia Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Fibromyalgia Therapeutics Report Years Considered
Figure 12. Global Fibromyalgia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Fibromyalgia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Fibromyalgia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Fibromyalgia Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Fibromyalgia Therapeutics Market Share by Players in 2020
Figure 17. Global Top Fibromyalgia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibromyalgia Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Fibromyalgia Therapeutics Revenue in 2020
Figure 19. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Fibromyalgia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Fibromyalgia Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Fibromyalgia Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Fibromyalgia Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Fibromyalgia Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Fibromyalgia Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Fibromyalgia Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Fibromyalgia Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Fibromyalgia Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Fibromyalgia Therapeutics Market Share by Region (2016-2027)
Figure 41. China Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Fibromyalgia Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Fibromyalgia Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Fibromyalgia Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Fibromyalgia Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Fibromyalgia Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Fibromyalgia Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Fibromyalgia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 62. Actavis Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 63. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 64. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 65. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 66. Meda Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 67. Meiji Seika Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 68. Switch Biotech Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 69. Theravance Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 70. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 71. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 72. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 73. Forest Pharmaceuticals, Inc. Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 74. Boehringer Ingelheim GmbH Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 75. Pierre Fabre Mdicament Revenue Growth Rate in Fibromyalgia Therapeutics Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の線維筋痛症治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Fibromyalgia Treatment Drug Market The global Fibromyalgia Treatment Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…- 世界の線維筋痛症治療薬市場規模・現状・予測（2021年-2027年） Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure. The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market. Market Analysis and Insights: Global Fibromyalgia Drugs Market The glob…
- 世界の線維筋痛症治療薬市場 2021：企業別、地域別、種類・用途別 The Fibromyalgia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界のサンドホフ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sandhoff Disease Therapeutics Market The global Sandhoff Disease Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界の院内感染症治療市場規模・現状・予測（2021年-2027年） Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…